Paterna solves male infertility through in vitro spermatogenesis (IVS) technology, enabling viable sperm production from stem cells to support genetic infertility solutions in clinical fertility treatments.
About the company
Paterna is a biotechnology company focused on solving complex male infertility challenges through in vitro spermatogenesis (IVS). Its proprietary technology produces mature, functional sperm from testicular stem cells, offering a vital solution for cases of azoospermia and other genetic infertility factors. Founded by leaders in reproductive biology, Paterna’s team brings together expertise from renowned institutions to deliver clinically sound, research-backed advancements in fertility treatments.
With partnerships at premier fertility networks, including IVI RMA Global, Paterna has strategically positioned itself to conduct robust clinical trials and accelerate technology adoption in real-world settings. This approach ensures a reliable pathway to market, aimed at enhancing fertility outcomes and expanding options for couples facing male infertility.
Why We Invested
Male infertility remains a critical unmet need in reproductive health, with few solutions addressing genetic factors in sperm development. Paterna’s innovative IVS technology not only fills this gap but does so with a biological approach that closely mimics natural sperm maturation, offering a viable alternative to conventional IVF techniques.
As the demand for fertility solutions grows, driven by later-life family planning and rising infertility rates, Paterna’s technology presents a transformative approach with substantial growth potential. Its early clinical partnerships and clear regulatory roadmap further support scalability and accelerated market entry, aligning with Seaside’s commitment to investing in pioneering health solutions with real-world impact.
By addressing a key obstacle in reproductive health, Paterna is poised to make a significant contribution to advancing fertility care. We are proud to support Paterna as they work to deliver meaningful, science-driven fertility solutions for individuals and couples worldwide.